The hart and bone in concert

Similar documents
Klotho: renal and extra-renal effects

Endocrine Regulation of Calcium and Phosphate Metabolism

The Skeletal Response to Aging: There s No Bones About It!

FGF23 (and Klotho): what s new? Brief introduction to FGF23. Introduction to FGF23. FGF23: phosphorylation pathways. FGF23: phosphorylation pathways

CKD: Bone Mineral Metabolism. Peter Birks, Nephrology Fellow

Secondary Hyperparathyroidism: Where are we now?

Do We Do Too Many Parathyroidectomies in Dialysis? Sagar Nigwekar MD, MMSc Massachusetts General Hospital

Calcium, phosphate & magnesium regulation

Therapeutic golas in the treatment of CKD-MBD

CKD-Mineral Bone Disorder (MBD) Pathogenesis of Metabolic Bone Disease. Grants: NIH, Abbott, Amgen, OPKO, Shire

The Role of the Laboratory in Metabolic Bone Disease

Hypophosphatemic rickets: new treatments

Metabolic Bone Disease Related to Chronic Kidney Disease

University of Zurich. What goes in must come out - the small intestine modulates renal phosphate excretion. Zurich Open Repository and Archive

KDIGO. CKD- MBD: Is the Term S2ll Jus2fied? Tilman B. Drüeke

International Journal of Health Sciences and Research ISSN:

Persistent post transplant hyperparathyroidism. Shiva Seyrafian IUMS-97/10/18-8/1/2019

Hyperparathyroidism: Operative Considerations. Financial Disclosures: None. Hyperparathyroidism. Hyperparathyroidism 11/10/2012

Chapter 6: SKELETAL SYSTEM

2017 KDIGO Guidelines Update

BEC FEED SOLUTIONS NEW ZEALAND Ltd

OMICS Journals are welcoming Submissions

OSTEOMALACIA UPDATE. Nothing to Disclose. Daniel D Bikle, MD, PhD Professor of Medicine University of California and VA Medical Center San Francisco

FGF23 in CKD and ESRD Regulator of phosphorus balance, or much more than that?

Thomas Carpenter Yale University School of Medicine New Haven, Connecticut, USA

Pr Dominique Prié, Université Paris Descartes, Faculté de Médecine,

Bone Metabolism in Postmenopausal Women Influenced by the Metabolic Syndrome

chapter 1 & 2009 KDIGO

Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease

Index. B BMC. See Bone mineral content BMD. See Bone mineral density Bone anabolic impact, Bone mass acquisition

Hyperphosphatemia is associated with a

Incorporating K/DOQI Using a Novel Algorithm Approach: Regina Qu Appelle s Experience

BONE AND MINERAL METABOLISM in the PD PATIENT

Tenapanor, a gastrointestinal NHE3 inhibitor, reduces serum phosphate in patients with chronic kidney disease stage 5D and hyperphosphatemia

Bone Remodeling & Repair Pathologies

DIAGNOSING X-LINKED HYPOPHOSPHATEMIA (XLH) BIOCHEMICAL TESTING CONSIDERATIONS

Chronic Kidney Disease-Mineral Bone Disoder: Fibroblast Growth Factor-23 and Phosphate Metabolism

Vitamin D Replacement ROCKY MOUNTAIN MEETING NOV 2013 BANFF W.COKE UNIVERSITY OF TORONTO

Vascular calcification in stage 5 Chronic Kidney Disease patients on dialysis

Bone Markers and Vascular Calcification in CKD-MBD

Ca, Mg metabolism, bone diseases. Tamás Kőszegi Pécs University, Department of Laboratory Medicine Pécs, Hungary

Decreasing Total Body Phosphorus Burden in Chronic Kidney Disease

ESPEN Congress Prague 2007

Vitamin D. Vitamin functioning as hormone. Todd A Fearer, MD FACP

Biochemistry #01 Bone Formation Dr. Nabil Bashir Farah Banyhany

Supplementary Information to Chapter 36

Vitamin D: Conflict of Interest Statement Corporate. Outline 7/5/2016

The impact of improved phosphorus control: use of sevelamer hydrochloride in patients with chronic renal failure

The Calcium Conundrum: When, What and How to Give Calcium in Pediatric CKD/ESRD

Hypocalcemia 6/8/12. Normal value. Physiologic functions. Nephron a functional unit of kidney. Influencing factors in Calcium and Phosphate Balance

Tenapanor, a gastrointestinal NHE3 inhibitor, reduces serum phosphate in patients with chronic kidney disease stage 5D and hyperphosphatemia

Elecsys bone marker panel. Optimal patient management starts in the laboratory

Vitamin D: Is it a superhero??

Regulation of the skeletal mass through the life span

Malnutrition and Role of Nutrition in BMD:CKD

Magnesium Homeostasis

Outline. The Role of Vitamin D in CKD. Essential Role of Vitamin D. Mechanism of Action of Vit D. Mechanism of Action of Vit D 7/16/2010

The Parathyroid Glands

PARATHYROID, VITAMIN D AND BONE

Normal kidneys filter large amounts of organic

The Parathyroid Glands Secrete Parathyroid Hormone, which Regulates Calcium, Magnesium, and Phosphate Ion Levels

Functions of the Skeletal System. Chapter 6: Osseous Tissue and Bone Structure. Classification of Bones. Bone Shapes

HYDROCHLORIDE FOR THE TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS WITH END-STAGE RENAL DISEASE ON MAINTENANCE DIALYSIS THERAPY

Calcium metabolism and the Parathyroid Glands. Calcium, osteoclasts and osteoblasts-essential to understand the function of parathyroid glands

The discovery of Vitamin D and the elimination of rickets has been considered as one of Medicine s Greatest Achievements.

Ca, Phos and Vitamin D Metabolism in Pre-Dialysis Patients

Secondary hyperparathyroidism in dialysis patients

Bone Health in Celiac Disease. Partha S. Sinha MD, PhD October 29 th, 2017

Protocol GTC : A Randomized, Open Label, Parallel Design Study of Sevelamer Hydrochloride (Renagel ) in Chronic Kidney Disease Patients.

FOCUS ON CARDIOVASCULAR DISEASE

Uremic Cardiomyopathy with a focus on the role of α-klotho and FGF23

Renal Control of Calcium, Phosphate, and Magnesium Homeostasis

J.Bacchetta has documented that she has received grants for research activities from Amgen, Crinex, Sandoz.

CKD-MBD CKD mineral bone disorder

Prof. Michel Jadoul Cliniques universitaires St-Luc Université Catholique de Louvain Brussels, Belgium. Slide 1

Fibroblast growth factor-23 in canine chronic kidney disease THESIS

Hyperparathyroidism. There is however another more potent method to achieve the lowering of PTH in a more natural way.

Management of CKD. Goce Spasovski, R. Macedonia

Effects of Diabetes Mellitus, Age, and Duration of Dialysis on Parathormone in Chronic Hemodialysis Patients. Hamid Nasri 1, Soleiman Kheiri 2

SKELETAL SYSTEM I NOTE: LAB ASSIGNMENTS for this topic will run over 3 Weeks. A SEPARATE WORKSHEET WILL BE PROVIDED.

9/26/2016. The Impact of Dietary Protein on the Musculoskeletal System. Research in dietary protein, musculoskeletal health and calcium economy

Vitamin D & Cardiovascular Disease

Should cinacalcet be used in patients who are not on dialysis?

The Management of Phosphataemia in Renal Dogs or Cats

Treatment Options for Chronic Kidney

The phosphatonin pathway: New insights in phosphate homeostasis.

Secondary hyperparathyroidism an Update on Pathophysiology and Treatment

New biological targets for CKD- MBD: From the KDOQI to the

Agents that Affect Bone & Mineral Homeostasis

FGF23 parathyroid interaction: implications in chronic kidney disease

Notes to/6 4- ( ea/2

Investigations for Disorders of Calcium, Phosphate and Magnesium Homeostasis

Cardiovascular Mortality: General Population vs ESRD Dialysis Patients

The Skeletal System:Bone Tissue

AACE Southern States Chapter Lecture. Basics

Understanding the molecular regulation of phosphate

The Parsabiv Beginner s Book

The Low Blood Level of 25-Hydroxy Vitamin D in African American Women: Is It Clinically Significant?

Amani Alghamdi. Slide 1

THE IMPACT OF SERUM PHOSPHATE LEVELS IN CKD-MBD PROGRESSION

Transcription:

The hart and bone in concert Piotr Rozentryt III Department of Cardiology, Silesian Centre for Heart Disease, Silesian Medical University, Zabrze, Poland

Disclosure Research grant, speaker`s fee, travel grants from Genzyme, Roche Diagnostics

Functions of the skeleton Locomotion Organ protection Settlement for bone marrow Calcium and phosphorus* reservoir and endocrine activity measured in plasma as inorganic phosphate (phosphate / phosphorus used interchangebly)

Plan of talk Clasic concept of Ca and Pi physiology New concepts in Ca and Pi regulation role of bone Reasons for Pi overload Pi toxicity and off-target actions of calciotropic hormones What can we done today based on evidence?

Clasic concept of Ca and Pi physiology New concepts in Ca and Pi regulation central role of bone Reasons for Pi overload Pi toxicity and off-target actions of calciotropic hormones What can we do today based on evidence?

Calcium Phosphorus Bone & teeth (hydroxyepatite) Intracellular > 99% < 0,005% ~ 85% ~ 14-15% Blood < 0,5% < 1% Regulation Intestinal absorption ~ 80% Intestinal absorption ~ 30% under control of 1,25(OH 2 )D 3 Renal excretion ~ 70% under control of PTH and klotho. Translocation between bones and blood (control of PTH, and many others) under control of 1,25(OH 2 )D 3 Renal excretion ~ 70% under control of PTH, phosphatonins and other factors Translocation between compartments highly changeable (control of PTH for bone unknown for others) Peacoc M. Clin J Am Soc Nephrol 2010;5:s23-230 Razzaque MS. Clin Sci 2011;120:91-7

Classic concept of calcium / phosphate regulation Ca ++ Parathyroid VDR CaS (-) PTH Kidney 1,25(OH 2 )D 3 Ca ++ 1alpha hydroxylase-25d 3 Bone NaPi-IIa, NaPi-IIc 25(OH)D 3 Small intestine NaPi-IIb Osteoclasts resorption Osteoblasts - synthesis resorption Ca ++ Pi Ca ++ absorption Pi efflux Ca ++ Pi

Clasic concept of Ca and Pi physiology New concepts in Ca and Pi regulation central role of bone Reasons for Pi overload Pi toxicity and off-target actions of calciotropic hormones What can we do today based on evidence?

Martin DR. Am J Physiol 2005;289:E729-E734.

Phosphatonin Circulating factor that induced renal inorganic phosphate wasting in patients with tumor-induced osteomalacia (TIO) Cai Q. N Engl J Med. 1994;330:1645-1649 FGF-23 fibroblast growth factor 23 is best described phosphatonin FGF-23 is secreted by osteocyts in response to rising concentration of phosphorus in small intestine or increased plasma level FGF-23 acts through FGF receptors but requires co-receptor klotho which defines target organs for FGF-23 active in phosphate homeostasis Kuro-O M. Trends Edocr Metab 2008;19:239-245

1500mg Pi/d 2300mg Pi/d 625mg Pi/d 13 healthy voluntiers Antoniucci DM. J Clin Endocrinol Metab 2006;91:3144-3149

Effects of FGF-23 neutralisation on plasma level of 1,25(OH 2 )D 3 in rats Effects of FGF-23 neutralisation on enzymatic activity of 1alphaOH hydroxylase and 24 hydroxylase in rats Hasegawa H. Kidney Int 2010;78:975-980

Klotho is expressed (organs that respond to FGF-23 using FGF receptors): Parathyroids Kidneys Brain (role of FGF23 not defined yet) Kuro-O M. Korean J Int Med. 2011;26:113-122

for FGF23 Gattineni J. Am J Physiol. 2009;297:F282 F291

Hamowanie PTH przez FGF-23 Komba H. Kidney Int 2010;77:292 298.

New concept of calcium / phosphate regulation PTH Parathyroid (+) FGFR1 Klotho VDR CaS Inactive metabolits (also catabolites of 25D3), 1,25(OH 2 )D 3 1,24 hydroxylase-25d 3 (+) FGF-23 Dietary or blood Pi Kidney (-) 1alpha hydroxylase-25d 3 FGFR1 Klotho NaPi-IIa, NaPi-IIc resorption Ca ++ Pi 25(OH)D 3 Small intestine Pi Ca ++ Bone Osteoclasts more active Osteoblasts less active (uncoupling) Modified Kuro-O. Kidney Int Suppl 2011;121:S20-S23.

Clasic concept of Ca and Pi physiology New concepts in Ca and Pi regulation central role of bone Reasons for Pi overload Pi toxicity and off-target actions of calciotropic hormones What can we do today based on evidence?

To much phosphorus and/or to much rapidly absorbed phosphorus in food (inorganic phosphorus from preservatives, conservants is absorbed 100% within minutes, from organic sources only 40-60% in hours) Food questionaries DO NOT capture this hidden phosphorus estimated to add 20-70% Murphy-Gutekunst L. J Ren Nutr 2005;15:e1-e6 Benieni O. J Ren Nutr 2011;21:303-3-8 Reduced ability of kidneys to excreate phosphorus Rapid translocation from intracellular compartments ie. tumor lysis syndrome and tissue hypoxia Howard SC. N Engl J Med. 2011;364:1844-1854

Flynn at al.: Intake of selected nutrients from foods, from fortification and from supplements in various European countriesintake of selected nutrients from foods, from fortification and from supplements in various European countries. Food Nutr Res 2009 700 mg UNDERESTIMATION BY 20-70% DUE TO PRESENCE OF HIDDEN Pi

Tucker KL. Am J Clin Nutr 2006;84:936 42.

The likelihood of plasma Pi >3.5 mg/dl in relation to oedema-free weight change in hart failure OR, 95% CI Adjusted for age, gender, GFR, ALP 772 patients with chronic hart failure and verying degree of oedema-free weight loss Rozentryt P. unpublished

Clasic concept of Ca and Pi physiology New concepts in Ca and Pi regulation central role of bone Reasons for Pi overload Pi toxicity and off-target actions of calciotropic hormones What can we do today based on evidence?

Meal with 400 mg of P Meal with 1200 mg of P preprandial postprandial 11 healthy voluntiers Shuto E. JASN 2009;20:1504-1512

The probability of CAC > 100 ua related to plasma phosphorus in patients with baseline normal CAC for each 1 mg/dl of Pi increase the probability of CAC>100 rose by 34% Follow-up = 17 years Baseline and follow-up CAC assessed by electron-beam computed tomography CARDIA Study N= 3015 mean baseline age = 25 y, mean Pi in diet = 1775 mg/d 3.9 mg/dl Foley RN. J Am Soc Nephrol 2009; 20: 397 404

Genetic inactivation of either klotho or FGF-23 n mice induces hyperphosphatemia and a phenotype of premature aging and shorter life span (vasular calcifications, osteoporosis, infertility, emphysema, muscle wasting, skin atrophy, central nervous system pathology) Biochemistry: Pi, Ca 1,25(OH 2 )D 3 Nakatani T. FASEB J 2009;23:433-441.

Interventions capable of rescuining premature aging phenotype in klotho KO or FGF23 KO mice Kuro-O M. Kidney Int Suppl. 2011;121:s20-s23. John GB. Am J Kidney Dis 2011;58:127-134.

Dhingra et al.: Relations of Serum Phosphorus and Calcium Levels to the Incidence of Cardiovascular Disease in the Community. Arch Int Med 2007 Tonelli at al.: Relation Between Serum Phosphate Level and Cardiovascular Event Rate in People With Coronary Disease. Circulation 2005

Off-target action of hormones regulating phosphorus homeostasis Hyperparathyroidism Higher level of FGF-23 Reduction of 1,25(OH 2 )D 3 and 25(OH)D 3

High Pi intake and tissue hypoxia with Induction translcation from intracellular stores may shift it to the left MOST TYPICAL CARDIAC PATIENTS ARE HERE Wolf M. J Am Soc Nephrol 2010;21:!427-1435

Uppsala Longitudinal Study of Adult Men N= 958 men, median follow-up = 9.7 years Hagstrom E. Circulation 2009;119:2765-2771

The association of FGF23 and left ventricle hypethrophy N=795 Age =70 Mirza MAI. 207 (2009) 546 551

Median value within lowest quartile of FGF23 taken as a referent CRIK study N=3879 patients with chronic kidney disease Stage 2-4 Isakova T. JAMA 2011;305:2432-2439

Cardiovascular mortality in relation to 25(OH)D 3 N=1194 Michaelson K. Am J Clin Nutr 2010;92:841 8.

Clasic concept of Ca and Pi physiology New concepts in Ca and Pi regulation central role of bone Reasons for Pi overload Pi toxicity and off-target actions of calciotropic hormones What can we do today based on evidence?

Reduction of nutritional Pi burden by diet? Type of diet may influence plasma phosphorus and FGF23 Moe SM. Clin J Am Soc Nephrol 2011;6:257-264

Reduction of nutritional Pi burden by binders? 127 dialysed patients treated with calcium containing Pi binder or with sevelamer non calcium containing Pi binder Block GA. Kidney International 2007; 71:38 441

Vitamin D supplementation? Autier P. Arch Intern Med. 2007;167(16):1730-1737

Summary Bones are an important endocrine organ FGF23 secreated by osteocytes is critical for systemic phosphorus balance Impairement of FGF23 endocrine functions may result in delataroius consequences We urgently need randomised trials to test interventions aiming at disrupted mineral homeostasis In patients free of significant kidney disease

Thank you for your attention